Swiss HIV Cohort Study
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
von Wyl V, Günthard H, Ledergerber B, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Cellerai C, Shah C, Böni J, Yerly S, Swiss HIV Cohort Study. Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clin Infect Dis 2011; 54:131-40.
Nov 4, 2011Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
Nov 4, 2011Clin Infect Dis 2011; 54:131-40
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Cellerai Cristina, Shah Cyril, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Scherrer A, Günthard H, Held L, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Hirschel B, Rauch A, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 2011; 53:1143-52.
Oct 13, 2011Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Oct 13, 2011Clin Infect Dis 2011; 53:1143-52
Scherrer Alexandra U, Günthard Huldrych F, Held Leonhard, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Rauch Andri, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Bernasconi E, Bertisch B, Cavassini M, Hirschel B, Battegay M, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-9.
Oct 13, 2011Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
Oct 13, 2011Clin Infect Dis 2011; 53:1130-9
Hasse Barbara, Weber Rainer, Bernasconi Enos, Bertisch Barbara, Cavassini Matthias, Hirschel Bernhard, Battegay Manuel, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
von Wyl V, Günthard H, Bonhoeffer S, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Staehelin C, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Böni J, Yerly S, Kouyos R, Swiss HIV Cohort Study. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 2011; 204:1095-103.
Oct 1, 2011The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
Oct 1, 2011J Infect Dis 2011; 204:1095-103
von Wyl Viktor, Günthard Huldrych F, Bonhoeffer Sebastian, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Staehelin Cornelia, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Böni Jürg, Yerly Sabine, Kouyos Roger D, Swiss HIV Cohort Study
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
di Iulio J, Rauch A, Telenti A, Klenerman P, Barnes E, Hirschel B, Schmid P, Bernasconi E, Battegay M, Günthard H, Furrer H, Pulit S, Martinez R, Fellay J, Rotger M, Kelleher D, Fitzmaurice K, Ciuffi A, Swiss HIV Cohort Study. Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology 2011; 53:1446-54.
May 1, 2011Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
May 1, 2011Hepatology 2011; 53:1446-54
di Iulio Julia, Rauch Andri, Telenti Amalio, Klenerman Paul, Barnes Eleanor, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Furrer Hansjakob, Pulit Sara, Martinez Raquel, Fellay Jacques, Rotger Margalida, Kelleher Dermot, Fitzmaurice Karen, Ciuffi Angela, Swiss HIV Cohort Study
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Haas A, Oxenius A, Günthard H, Macpherson A, Patuto N, Vernazza P, Hirschel B, Battegay M, Thurnheer M, Weber R, Bossart W, Ledergerber B, Rusert P, Slack E, Graw F, Zimmermann K, Swiss HIV Cohort Study. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011; 60:1506-19.
Apr 21, 2011Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Apr 21, 2011Gut 2011; 60:1506-19
Haas Anna, Oxenius Annette, Günthard Huldrych F, Macpherson Andrew J, Patuto Nicola, Vernazza Pietro, Hirschel Bernard, Battegay Manuel, Thurnheer Maria C, Weber Rainer, Bossart Walter, Ledergerber Bruno, Rusert Peter, Slack Emma, Graw Frederik, Zimmermann Kathrin, Swiss HIV Cohort Study
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
Kaufmann G, Battegay M, Hirschel B, Bernasconi E, Vernazza P, Giulieri S, Furrer H, Weber R, Elzi L, Swiss HIV Cohort Study. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS 2011; 25:441-51.
Feb 20, 2011Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
Feb 20, 2011AIDS 2011; 25:441-51
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Giulieri Stefano, Furrer Hansjakob, Weber Rainer, Elzi Luigia, Swiss HIV Cohort Study
Clinical relevance of cytomegalovirus viraemia(*,†)
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Hasse B, Kaiser L, Calmy A, Yerly S, Combescure C, Swiss HIV Cohort Study. Clinical relevance of cytomegalovirus viraemia(*,†). HIV Med 2011; 12:394-402.
Jan 19, 2011Clinical relevance of cytomegalovirus viraemia(*,†)
Jan 19, 2011HIV Med 2011; 12:394-402
El Amari E Boffi, Hirschel B, Bernasconi E, Hirsch Hh, Vernazza Pietro, Cavassini M, Furrer H, Hasse B, Kaiser L, Calmy A, Yerly S, Combescure C, Swiss HIV Cohort Study
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Ortiz M, Tarr P, Telenti A, Günthard H, Ledergerber B, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Elzi L, Arnedo M, Martinez R, Kovari H, Furrer H, Poloni E, Swiss HIV Cohort Study. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 2011; 203:620-4.
Jan 12, 2011No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Jan 12, 2011J Infect Dis 2011; 203:620-4
Ortiz Millán, Tarr Philip E, Telenti Amalio, Günthard Huldrych F, Ledergerber Bruno, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Bernasconi Enos, Elzi Luigia, Arnedo Mireia, Martinez Raquel, Kovari Helen, Furrer Hansjakob, Poloni Estella S, Swiss HIV Cohort Study
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
Kouyos R, Cavassini M, Rauch A, Battegay M, Vernazza P, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard H, Hirschel B, Weber R, Klimkait T, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, Taffé P, Shah C, Bürgisser P, Swiss HIV Cohort Study. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 2011; 52:532-9.
Jan 10, 2011Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
Jan 10, 2011Clin Infect Dis 2011; 52:532-9
Kouyos Roger D, Cavassini Matthias, Rauch Andri, Battegay Manuel, Vernazza Pietro, Bernasconi Enos, Ledergerber Bruno, Bonhoeffer Sebastian, Günthard Huldrych F, Hirschel Bernard, Weber Rainer, Klimkait Thomas, von Wyl Viktor, Yerly Sabine, Böni Jürg, Rieder Philip, Joos Beda, Taffé Patrick, Shah Cyril, Bürgisser Philippe, Swiss HIV Cohort Study
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Rotger M, Tarr P, Telenti A, Egger M, Ledergerber B, Weber R, Furrer H, Hirschel B, Bernasconi E, Cavassini M, Vernazza P, Elzi L, Taffé P, Martinez R, Gsponer T, Swiss HIV Cohort Study. Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clin Infect Dis 2010; 51:1090-8.
Nov 1, 2010Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Nov 1, 2010Clin Infect Dis 2010; 51:1090-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Egger Matthias, Ledergerber Bruno, Weber Rainer, Furrer Hansjakob, Hirschel Bernard, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Elzi Luigia, Taffé Patrick, Martinez Raquel, Gsponer Thomas, Swiss HIV Cohort Study
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Nicca D, Bernasconi E, Cavassini M, Elzi L, Evison J, Jeannin A, Glass T, Vernazza P, Hirschel B, Ledergerber B, Swiss HIV Cohort Study. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314-22.
Oct 29, 2010Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
Oct 29, 2010Clin Infect Dis 2010; 51:1314-22
Hasse Barbara, Weber Rainer, Nicca Dunja, Bernasconi Enos, Cavassini Matthias, Elzi Luigia, Evison John-Marc, Jeannin Andre, Glass Tracy R, Vernazza Pietro, Hirschel Bernard, Ledergerber Bruno, Swiss HIV Cohort Study
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
Alizon S, Bonhoeffer S, Günthard H, Telenti A, Bürgisser P, Battegay M, Bernasconi E, Vernazza P, Rauch A, Furrer H, Klimkait T, Shah C, Böni J, Hirschel B, Yerly S, Kouyos R, Stadler T, von Wyl V, Swiss HIV Cohort Study. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog 2010; 6
Sep 30, 2010Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
Sep 30, 2010PLoS Pathog 2010; 6
Alizon Samuel, Bonhoeffer Sebastian, Günthard Huldrych F, Telenti Amalio, Bürgisser Philippe, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Rauch Andri, Furrer Hansjakob, Klimkait Thomas, Shah Cyril, Böni Jürg, Hirschel Bernard, Yerly Sabine, Kouyos Roger D, Stadler Tanja, von Wyl Viktor, Swiss HIV Cohort Study
Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study
Thurnheer M, Furrer H, Zwahlen M, Christen A, Bernasconi E, Schmid P, Elzi L, Cavassini M, Toutous-Trellu L, Weber R, Swiss HIV Cohort Study. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS 2010; 24:1907-16.
Jul 31, 2010Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study
Jul 31, 2010AIDS 2010; 24:1907-16
Thurnheer Maria Christine, Furrer Hansjakob, Zwahlen Marcel, Christen Anna B, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Toutous-Trellu Laurence, Weber Rainer, Swiss HIV Cohort Study
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Lubomirov R, Telenti A, Csajka C, Decosterd L, Buclin T, Descombes P, Rentsch K, Ledergerber B, Cavassini M, Calmy A, Vernazza P, Furrer H, Marzolini C, Martinez R, Colombo S, Fayet A, di Iulio J, Swiss HIV Cohort Study. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenet Genomics 2010; 20:217-30.
Apr 1, 2010ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Apr 1, 2010Pharmacogenet Genomics 2010; 20:217-30
Lubomirov Rubin, Telenti Amalio, Csajka Chantal, Decosterd Laurent A, Buclin Thierry, Descombes Patrick, Rentsch Katharina, Ledergerber Bruno, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Furrer Hansjakob, Marzolini Catia, Martinez Raquel, Colombo Sara, Fayet Aurélie, di Iulio Julia, Swiss HIV Cohort Study
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
Jan 11, 2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Jan 11, 2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Elzi L, Battegay M, Weber R, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Furrer H, Marzolini C, Swiss HIV Cohort Study. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of internal medicine 2010; 170:57-65.
Jan 11, 2010Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Jan 11, 2010Archives of internal medicine 2010; 170:57-65
Elzi Luigia, Battegay Manuel, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Ledergerber Bruno, Furrer Hansjakob, Marzolini Catia, Swiss HIV Cohort Study
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia
Ferry T, Calmy A, Schmid P, Bernasconi E, Elzi L, Weber R, Rauch A, Delhumeau C, Meylan P, Dang T, Hirschel B, Swiss HIV Cohort Study. Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 50:115-8.
Jan 1, 2010Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia
Jan 1, 2010Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 50:115-8
Ferry Tristan, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Elzi Luigia, Weber Rainer, Rauch Andri, Delhumeau Cécile, Meylan Pascal, Dang Thanh, Hirschel Bernard, Swiss HIV Cohort Study
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Marzolini C, Battegay M, Back D, Ledergerber B, Khoo S, Vernazza P, Calmy A, Bernasconi E, Cavassini M, Chave J, Furrer H, Fux C, Weber R, Gibbons S, Elzi L, Swiss HIV Cohort Study. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther (Lond) 2010; 15:413-23.
Jan 1, 2010Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Jan 1, 2010Antivir Ther (Lond) 2010; 15:413-23
Marzolini Catia, Battegay Manuel, Back David, Ledergerber Bruno, Khoo Saye, Vernazza Pietro, Calmy Alexandra, Bernasconi Enos, Cavassini Matthias, Chave Jean-Philippe, Furrer Hansjakob, Fux Christoph, Weber Rainer, Gibbons Sara, Elzi Luigia, Swiss HIV Cohort Study
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Rotger M, Tarr P, Telenti A, Ledergerber B, Weber R, Witteck A, Furrer H, Hirschel B, Battegay M, Bernasconi E, Cavassini M, Martinez R, Taffé P, Bayard C, Swiss HIV Cohort Study. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation. Cardiovascular genetics 2009; 2:621-8.
Dec 1, 2009Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Dec 1, 2009Circulation. Cardiovascular genetics 2009; 2:621-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Weber Rainer, Witteck Andrea, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Bernasconi Enos, Cavassini Matthias, Martinez Raquel, Taffé Patrick, Bayard Cornelia, Swiss HIV Cohort Study